Auro Laboratories Ltd Share Price Today - Auro Laboratories Ltd Stock Price Live NSE/BSE

Auro Laboratories Ltd

NSE: BSE: 530233

₹267

(0.81%)

Wed, 29 Apr 2026, 01:20 pm

MTF 5xInvest in Auro Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap0

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Auro Laboratories Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
159.40
Net Profit
1.84
P/B
3.34
Sector P/E
33.33
P/E
78.15
EV/EBITDA
45.76
Debt/Equity (Industry)
0.17
Interest Cover (Industry)
18.19
ROCE (Industry)
20.67
RONW (Industry)
17.71
ROE
4.33
ROCE
3.79
Debt/Equity
0.81
EPS (TTM)
2.95
Dividend Yield
0
Book Value
68.95
Interest Cover
2.74

Analysis

all

Pros

Auro Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Auro Laboratories is profitable, therefore cash runway is not a concern.
Auro Laboratories is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (290.7%, greater than 20% of total debt).
Debt is covered by short term assets, assets are 4.4x debt.

Cons

Unable to evaluate Auro Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Auro Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
High level of physical assets or inventory.
Sharat's remuneration is higher than average for companies of similar size in India.
Auro Laboratories is not covered by any analysts.

Financials

No Result Found

Ratios

No Result Found

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	52.18	52.18	52.18	52.18	52.18
FII	0	0	0	0	0
DII	0.01	0.01	0.01	0.01	0.01
Public	47.82	47.82	47.82	47.82	47.82
Government	0	0	0	0	0

Technical Analysis

RSI

38.86

MACD

-5.24

50 DMA

276.54

200 DMA

249.53

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	366	319	292	272	245	225	178
Fibonacci	319	301.05	289.95	272	254.05	242.95	225
Camarilla	277.93	273.62	269.31	272	260.69	256.38	252.07

Pivots Level: Classic

+94

366

+47

319

+20

292

272

Pivot Point

LTP: 247.65

-27

245

-47

225

-94

178

Moving Average

SMAEMA

Period

Value

10-EMA
258.07
20-EMA
262.69
30-EMA
265.21
50-EMA
265.75
100-EMA
260.52
200-EMA
252.52

Announcement Date	Purpose	Action
05 Feb 2026	board-meetings	Quarterly Results
23 Aug 2025	agm
25 May 2024	agm
30 Aug 2023	agm
24 Jun 2022	agm
05 Aug 2021	agm

Peer Comparison

No Result Found

Auro Laboratories Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd

Cipla Ltd

Auro Laboratories Ltd About

Auro Laboratories company is dealing in the business of Active Pharmaceutical Ingredients.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1989

Headquarters

CEO

Sharat Deorah

Employees

Contact

Website

http://www.aurolabs.com

auro@aurolabs.com

Phone

91-22-66635456

Location

K-56 MIDC Indl Area, Tarapur Boisar, Thane, Maharashtra, 401506

Year	History
1989	Auro Laboratories Limited was incorporated as a Private Limited Company.
1992	The Company started its commercial production.
1993	The Company passed a resolution to convert into a Limited Company.
1994	The Company was converted into a Limited Company. The Company received the Letter of Intent for the production of 3-4-5 TMBA.
2006	The Company received Certificate of Suitability (COS) of Metformin Hydrochloride from EDQM.

Client Name	Order Side	QTY	Avg Price	Date
PADRONE MARKETING PVT LTD	Buy	50000	134.87	31 Aug 2023
AMIT DHANYAKUMAR CHORDIA	Sell	31240	80.78	30 Jun 2023
AMIT DHANYAKUMAR CHORDIA	Buy	50000	97.64	18 May 2023
VIVEK MEHROTRA	Sell	41944	140.97	10 Jan 2022
JAYSHREE VINOD SHAH	Sell	67656	80.34	12 Apr 2021
JAYSHREE VINOD SHAH	Sell	200000	5.8	17 Dec 2013
SHARAT . DEORAH	Buy	100000	5.8	17 Dec 2013
MEENA SHARAT DEORAH	Buy	100000	5.8	17 Dec 2013
SNEHALATHA SINGHI	Sell	41322	6.55	22 Aug 2012

Auro Laboratories Ltd News

Auro Laboratories Gets BB+ Credit Rating from Acuite

Auro Laboratories Limited receives ACUITE BB+ stable rating for Rs.64.20 crore long-term facilities and ACUITE A4+ for Rs.15.60 crore short-term facilities from Acuite Ratings.

14 Apr 2026

companies

Auro Labs Files Q4FY26 Demat Compliance Certificate

Auro Laboratories submits quarterly certificate under SEBI regulations for dematerialization activities during Q4FY26, with registrar confirming proper processing of share certificates.

14 Apr 2026

companies

Auro Labs Q3FY26 Revenue Surges 206% to ₹939.30 Lakhs

Auro Laboratories reports strong Q3FY26 performance with revenue jumping 206% YoY to ₹939.30 lakhs and net profit soaring to ₹195.18 lakhs from ₹5.10 lakhs in Q3FY25.

05 Feb 2026

co actions results

Auro Labs Board Meet on Feb 5 for Q3FY26 Results

Auro Laboratories Limited has scheduled a board meeting on February 05, 2026, to consider and approve unaudited financial results for the quarter ended December 31, 2025. Trading window remains closed for designated persons.

28 Jan 2026

co actions results

Auro Laboratories Receives WHO-GMP Certificate for API Manufacturing Facility

Auro Laboratories Limited has successfully completed a World Health Organization inspection at its Active Pharmaceutical Ingredients manufacturing facility located in MIDC Tarapur, Maharashtra. The company received a WHO-GMP Certificate from the Food Drug Administration, Maharashtra, which remains valid until September 30, 2028. The certification covers the company's bulk drugs manufacturing operations at the Tarapur location.

13 Nov 2025

stock

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800